Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

493.22
+10.152.10%
Post-market: 494.000.7800+0.16%19:59 EDT
Volume:1.50M
Turnover:740.33M
Market Cap:53.27B
PE:12.51
High:499.88
Open:485.54
Low:485.00
Close:483.07
Loading ...

Regeneron Pharmaceuticals Inc - Regulatory Applications Submitted in U.S. and EU for Libtayo

THOMSON REUTERS
·
31 May

Regeneron Pharmaceuticals Submits Regulatory Applications for Libtayo in Adjuvant Treatment of High-Risk CSCC in US and EU

Reuters
·
31 May

Post-Bell | S&P 500 Posts Biggest Monthly Pct Gain Since November 2023; Nvidia and Tesla Drop 3%; Gap Sinks 20%

Tiger Newspress
·
31 May

Regeneron price target lowered to $645 from $686 at Leerink

TIPRANKS
·
31 May

Regeneron dashes Wall Street's hopes as COPD treatment trial suffers a failure

Dow Jones
·
31 May

BUZZ-U.S. STOCKS ON THE MOVE-RBB Bancorp, Seacoast, GATX

Reuters
·
31 May

Regeneron (REGN) Gets a Buy from Guggenheim

TIPRANKS
·
31 May

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-05-30

Reuters
·
30 May

Regeneron Down Over 16%, On Track for Largest Percent Decrease Since April 2011 -- Data Talk

Dow Jones
·
30 May

Regeneron (REGN) Gets a Buy from Morgan Stanley

TIPRANKS
·
30 May

Regeneron Shares Set for Worst Day Since 2011; Last Down 17.8%

THOMSON REUTERS
·
30 May

Regeneron Shares Fall 15.8%; Co and Sanofi's Drug Itepekimab Met Main Goal in One Out of Two Late-Stage Trials

THOMSON REUTERS
·
30 May

US STOCKS-Wall St set for lower open as Trump says China violated tariff terms

Reuters
·
30 May

Sector Update: Health Care Stocks Fall Pre-Bell Friday

MT Newswires Live
·
30 May

Wells Fargo Downgrades Regeneron Pharmaceuticals to Equal Weight From Overweight, $580 Price Target

MT Newswires Live
·
30 May

Exchange-Traded Funds Mixed, Equity Futures Lower Pre-Bell Friday Amid US Tariff Reinstatement Decision

MT Newswires Live
·
30 May

Regeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints

TIPRANKS
·
30 May

Regeneron Shares Slide On Mixed Trial Data For Smoker's Lung Drug

Reuters
·
30 May

BUZZ-Regeneron slumps after closely watched smoker's lung drug fails trial

Reuters
·
30 May

Regeneron Shares Extend Premarket Fall; Last Down 11.7%

THOMSON REUTERS
·
30 May